TY  - JOUR
IS  - 9
N1  - This version is the version of record. For information on re-use, please refer to the publisher's terms and conditions.
TI  - Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views
AV  - public
VL  - 2021
Y1  - 2021/09/03/
JF  - Cochrane Database of Systematic Reviews
A1  - Engel, N
A1  - Ochodo, EA
A1  - Karanja, PW
A1  - Schmidt, BM
A1  - Janssen, R
A1  - Steingart, KR
A1  - Oliver, S
N2  - Objectives: This is a protocol for a Cochrane Review (qualitative). The objectives are as follows: 
To synthesize end?user and professional user perspectives and experiences with low?complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance. // 
Review question: What are the perspectives and experiences of people providing and receiving low?complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance? Answering this question will allow us to identify the implications for effective implementation and health equity.
ID  - discovery10138013
UR  - https://doi.org/10.1002/14651858.CD014877
SN  - 1469-493X
ER  -